Revolution Medicines, Inc. RVMD Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $383.75M-29.3% | $543.06M-22.0% | $696.15M+331% | $161.41M+48.8% | ||
| $1.64B-6.0% | $1.75B+51.0% | $1.16B+139% | $483.53M+3.2% | ||
| $4.86M+31.4% | $3.7M+22.0% | $3.03M+74.5% | $1.74M0.0% | ||
| $166.51M+30.4% | $127.67M+132% | $55.09M+6.1% | $51.92M+69.3% | ||
| $2.08B-10.9% | $2.33B+23.9% | $1.88B+185% | $660.19M+11.9% | ||
| $33.19M+36.7% | $24.29M+6.2% | $22.87M+22.5% | $18.66M+61.6% | ||
| $132.08M+12.4% | $117.53M+52.3% | $77.15M+40.1% | $55.08M-7.7% | ||
| $14.61M0.0% | $14.61M0.0% | $14.61M0.0% | $14.61M0.0% | ||
| $55.8M-1.5% | $56.67M-1.9% | $57.74M-1.8% | $58.81M-1.8% | ||
| $14.78M+748% | $1.74M-75.2% | $7.03M+146% | $2.86M+277% | ||
| $2.35B-8.0% | $2.56B+24.1% | $2.06B+154% | $811.93M+10.0% | ||
| $243.73M+73.4% | $140.58M-0.4% | $141.11M+90.9% | $73.93M+65.6% | ||
| $16.47M+27.9% | $12.87M+74.7% | $7.37M+8.8% | $6.77M+9.0% | ||
| $290.42M+77.2% | $163.91M+13.9% | $143.85M+132% | $61.98M+2.7% | ||
| $142.23M+15.7% | $122.97M+52.6% | $80.58M+40.3% | $57.43M-4.9% | ||
| $158.7M+16.8% | $135.84M+54.5% | $87.94M+37.0% | $64.21M-3.6% | ||
| $1.21M+80.3% | $670K-54.0% | $1.46M+384% | $301K-52.5% | ||
| $723.21M+147% | $293.1M+24.5% | $235.51M+85.8% | $126.74M-6.4% | ||
| $0— | $0— | $0— | $0— | ||
| $19K+5.6% | $18K+12.5% | $16K+77.8% | $9K+12.5% | ||
| $4.5B+12.4% | $4B+35.0% | $2.96B+113% | $1.39B+31.5% | ||
| -$2.87B-65.1% | -$1.74B-52.7% | -$1.14B-62.2% | -$701.34M-54.9% | ||
| $3.24M+145% | $1.32M+143% | $544K+131% | -$1.78M-373% | ||
| $1.63B-28.0% | $2.27B+24.0% | $1.83B+167% | $685.19M+13.7% | ||
| $2.35B-8.0% | $2.56B+24.1% | $2.06B+154% | $811.93M+10.0% | ||
| $1.64B-6.0% | $1.75B+51.0% | $1.16B+139% | $483.53M+3.2% | ||
| $14.78M+748% | $1.74M-75.2% | $7.03M+146% | $2.86M+277% | ||
| $24.15M+99.1% | $12.13M— | —— | —— | ||
| $132.08M+12.4% | $117.53M+52.3% | $77.15M+40.1% | $55.08M-7.7% | ||
| $55.8M-1.5% | $56.67M-1.9% | $57.74M-1.8% | $58.81M-1.8% | ||
| $132.08M+12.4% | $117.53M+52.3% | $77.15M+40.1% | $55.08M-7.7% | ||
| $14.78M+748% | $1.74M-75.2% | $7.03M+146% | $2.86M+277% | ||
| $132.08M+12.4% | $117.53M+52.3% | $77.15M+40.1% | $55.08M-7.7% | ||
| $14.78M+748% | $1.74M-75.2% | $7.03M+146% | $2.86M+277% | ||
| $268.45M— | $0— | —— | —— | ||
| $209.34M+117% | $96.62M+29.3% | $74.69M+154% | $29.45M+6.2% | ||
| $4.5B+12.4% | $4B+35.0% | $2.96B+113% | $1.39B+31.5% | ||
| $19K+5.6% | $18K+12.5% | $16K+77.8% | $9K+12.5% | ||
| $0— | $0— | $0— | $0— | ||
| $268.45M— | $0— | —— | —— | ||
| $2.35M0.0% | $2.35M-24.5% | $3.12M-55.7% | $7.03M-5.6% | ||
| $18.55M+482% | $3.19M-51.0% | $6.51M— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Revolution Medicines, Inc.'s total assets?
- Revolution Medicines, Inc. (RVMD) holds $2.3B in total assets, down 4.7% year over year.
- How much debt does Revolution Medicines, Inc. have?
- Revolution Medicines, Inc. carries $156.6M in total debt against $1.5B of shareholders' equity, a debt-to-equity ratio of 0.10.
- How much cash does Revolution Medicines, Inc. have?
- Revolution Medicines, Inc. holds $440.9M in cash and equivalents.
- Can Revolution Medicines, Inc. cover its short-term obligations?
- Its current ratio is 6.80 — current assets exceed current liabilities.
- Where does Revolution Medicines, Inc.'s balance sheet data come from?
- Every line is extracted from Revolution Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.